Detailed information for compound 116374

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 535.613 | Formula: C28H34FN7O3
  • H donors: 2 H acceptors: 4 LogP: 1.95 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 2
  • SMILES: CN1CCN(CC1)C(=O)[C@]1(C)CO[C@H](OC1)c1[nH]c(c(n1)c1ccc(cc1)F)c1ccnc(n1)NCC1CC1
  • InChi: 1S/C28H34FN7O3/c1-28(26(37)36-13-11-35(2)12-14-36)16-38-25(39-17-28)24-33-22(19-5-7-20(29)8-6-19)23(34-24)21-9-10-30-27(32-21)31-15-18-3-4-18/h5-10,18,25H,3-4,11-17H2,1-2H3,(H,33,34)(H,30,31,32)/t25-,28-
  • InChiKey: LHVMOVISOAUTPX-FCMXBYMOSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens mitogen-activated protein kinase 11 References
Homo sapiens mitogen-activated protein kinase 12 References
Mus musculus mitogen-activated protein kinase 13 Starlite/ChEMBL References
Mus musculus mitogen-activated protein kinase 14 References
Mus musculus mitogen-activated protein kinase 12 Starlite/ChEMBL References
Homo sapiens mitogen-activated protein kinase 14 References
Mus musculus mitogen-activated protein kinase 11 References
Homo sapiens mitogen-activated protein kinase 13 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Trypanosoma congolense mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania donovani mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Candida albicans MAP kinase involved in osmoregulation Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma cruzi mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania infantum mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Brugia malayi P38 map kinase family protein 2 Get druggable targets OG5_128610 All targets in OG5_128610
Schistosoma japonicum ko:K04441 p38 MAP kinase, putative Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma brucei gambiense mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus granulosus mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Loa Loa (eye worm) CMGC/MAPK/P38 protein kinase Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma brucei mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania mexicana mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Candida albicans MAP kinase involved in osmoregulation Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania major mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma cruzi mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania braziliensis mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus granulosus mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma brucei mitogen-activated protein kinase 5 mitogen-activated protein kinase 13 366 aa 371 aa 31.0 %
Trypanosoma brucei mitogen-activated protein kinase 5 mitogen-activated protein kinase 11 364 aa 361 aa 33.2 %
Trypanosoma brucei mitogen-activated protein kinase 5 mitogen-activated protein kinase 14 360 aa 336 aa 33.3 %
Trypanosoma brucei mitogen-activated protein kinase 5 mitogen-activated protein kinase 13 365 aa 366 aa 30.1 %
Trypanosoma brucei mitogen-activated protein kinase 5 mitogen-activated protein kinase 14 360 aa 336 aa 33.3 %
Trypanosoma brucei mitogen-activated protein kinase 5 mitogen-activated protein kinase 12 367 aa 363 aa 32.0 %
Trypanosoma brucei mitogen-activated protein kinase 5 mitogen-activated protein kinase 12 357 aa 362 aa 30.1 %
Trypanosoma brucei mitogen-activated protein kinase 5 mitogen-activated protein kinase 11 364 aa 361 aa 33.0 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Toxoplasma gondii 3-oxo-5-alpha-steroid 4-dehydrogenase 0.0198 0.0302 1
Loa Loa (eye worm) hypothetical protein 0.0112 0.0111 0.0591
Echinococcus multilocularis mitogen activated protein kinase 11 0.0914 0.1885 0.1885
Treponema pallidum fructose-bisphosphate aldolase 0.0316 0.0563 0.5
Brugia malayi Rhodanese-like domain containing protein 0.0112 0.0111 0.0591
Entamoeba histolytica rodhanase-like domain containing protein 0.0112 0.0111 0.1851
Loa Loa (eye worm) hypothetical protein 0.0198 0.0302 0.1603
Leishmania major 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein 0.0198 0.0302 0.0651
Echinococcus multilocularis m phase inducer phosphatase(cdc25) 0.0112 0.0111 0.0111
Trichomonas vaginalis cdc25b, putative 0.0112 0.0111 0.1851
Trichomonas vaginalis cdc25c, putative 0.0112 0.0111 0.1851
Schistosoma mansoni m-phase inducer phosphatase(cdc25) 0.0112 0.0111 0.4911
Echinococcus multilocularis thymidine phosphorylase 0.4583 1 1
Loa Loa (eye worm) hypothetical protein 0.0065 0.0009 0.0046
Trichomonas vaginalis m-phase inducer phosphatase, putative 0.0112 0.0111 0.1851
Brugia malayi Synaptic glycoprotein SC2 0.0065 0.0009 0.0046
Plasmodium falciparum polyprenol reductase, putative 0.0065 0.0009 0.5
Mycobacterium ulcerans thymidine phosphorylase 0.4583 1 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0316 0.0563 1
Trypanosoma brucei mitochondrial DNA polymerase beta-PAK 0.0148 0.0192 0.0976
Echinococcus multilocularis mitogen activated protein kinase 14 0.0914 0.1885 0.1885
Mycobacterium tuberculosis Probable anthranilate phosphoribosyltransferase TrpD 0.1294 0.2726 0.2573
Echinococcus granulosus m phase inducer phosphatasecdc25 0.0112 0.0111 0.0111
Entamoeba histolytica steroid 5-alpha reductase, putative 0.0198 0.0302 0.5293
Plasmodium vivax polyprenol reductase, putative 0.0065 0.0009 0.5
Trichomonas vaginalis mitotic inducer phosphatase CDC25, putative 0.0112 0.0111 0.1851
Echinococcus multilocularis mitogen activated protein kinase 14 0.0914 0.1885 0.1885
Mycobacterium ulcerans hypothetical protein 0.0198 0.0302 0.0098
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0198 0.0302 0.5293
Trypanosoma brucei 3-oxo-5-alpha-steroid 4-dehydrogenase-like, putative 0.0198 0.0302 0.1564
Trichomonas vaginalis m-phase inducer phosphatase, putative 0.0112 0.0111 0.1851
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0198 0.0302 0.5293
Entamoeba histolytica rodhanase-like domain containing protein 0.0112 0.0111 0.1851
Trypanosoma cruzi 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0198 0.0302 0.1564
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0316 0.0563 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0316 0.0563 1
Onchocerca volvulus 0.0112 0.0111 1
Trypanosoma brucei mitochondrial DNA polymerase beta 0.0313 0.0556 0.2917
Loa Loa (eye worm) hypothetical protein 0.0103 0.0092 0.0488
Echinococcus granulosus mitogen activated protein kinase 11 0.0914 0.1885 0.1885
Brugia malayi P38 map kinase family protein 2 0.0914 0.1885 1
Plasmodium vivax 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0065 0.0009 0.5
Schistosoma mansoni synaptic glycoprotein sc2 related 0.0065 0.0009 0.0385
Trichomonas vaginalis cdc25b, putative 0.0112 0.0111 0.1851
Loa Loa (eye worm) hypothetical protein 0.0112 0.0111 0.0591
Trypanosoma brucei mitogen-activated protein kinase 3, putative 0.0914 0.1885 1
Mycobacterium leprae Probable anthranilate phosphoribosyltransferase TrpD 0.1294 0.2726 1
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.0313 0.0556 0.2917
Mycobacterium ulcerans anthranilate phosphoribosyltransferase 0.1294 0.2726 0.2573
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative 0.0316 0.0563 1
Echinococcus multilocularis 3 oxo 5 alpha steroid 4 dehydrogenase, C terminal 0.0065 0.0009 0.0009
Loa Loa (eye worm) CMGC/MAPK/P38 protein kinase 0.0914 0.1885 1
Onchocerca volvulus 0.0112 0.0111 1
Echinococcus multilocularis geminin 0.0164 0.0227 0.0227
Echinococcus granulosus mitogen activated protein kinase 14 0.0914 0.1885 0.1885
Brugia malayi Rhodanese-like domain containing protein 0.0112 0.0111 0.0591
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0316 0.0563 1
Leishmania major mitochondrial DNA polymerase beta 0.0313 0.0556 0.2151
Echinococcus granulosus synaptic glycoprotein sc2 0.0065 0.0009 0.0009
Schistosoma mansoni hypothetical protein 0.0164 0.0227 1
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative 0.0316 0.0563 1
Trypanosoma cruzi mitogen-activated protein kinase 3, putative 0.0914 0.1885 1
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.0313 0.0556 0.2917
Echinococcus multilocularis mitogen activated protein kinase 11 0.0914 0.1885 0.1885
Onchocerca volvulus 0.0112 0.0111 1
Loa Loa (eye worm) hypothetical protein 0.0103 0.0092 0.0488
Trypanosoma cruzi 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0198 0.0302 0.1564
Trypanosoma cruzi mitogen-activated protein kinase 3, putative 0.0914 0.1885 1
Mycobacterium ulcerans hypothetical protein 0.0165 0.0229 0.0023
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0198 0.0302 0.5293
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0316 0.0563 1
Mycobacterium tuberculosis Conserved hypothetical protein 0.0165 0.0229 0.0023
Schistosoma mansoni hypothetical protein 0.0164 0.0227 1
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.0148 0.0192 0.0976
Onchocerca volvulus 0.0112 0.0111 1
Plasmodium falciparum 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0065 0.0009 0.5
Echinococcus granulosus geminin 0.0164 0.0227 0.0227
Entamoeba histolytica rodhanase-like domain containing protein 0.0112 0.0111 0.1851
Trichomonas vaginalis mitotic inducer phosphatase CDC25, putative 0.0112 0.0111 0.1851
Mycobacterium tuberculosis Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) 0.4583 1 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0316 0.0563 1
Trichomonas vaginalis mitotic inducer phosphatase CDC25, putative 0.0112 0.0111 0.1851
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0316 0.0563 1
Giardia lamblia Fructose-bisphosphate aldolase 0.0316 0.0563 1
Loa Loa (eye worm) hypothetical protein 0.0065 0.0009 0.0046
Schistosoma mansoni synaptic glycoprotein sc2 related 0.0065 0.0009 0.0385
Leishmania major mitogen-activated protein kinase 3, putative,map kinase 3, putative 0.0914 0.1885 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0316 0.0563 1
Brugia malayi 3-oxo-5-alpha-steroid 4-dehydrogenase 1 0.0198 0.0302 0.1603
Echinococcus granulosus 3 oxo 5 alpha steroid 4 dehydrogenase C terminal 0.0065 0.0009 0.0009
Echinococcus multilocularis synaptic glycoprotein sc2 0.0065 0.0009 0.0009

Activities

Activity type Activity value Assay description Source Reference
AUC (ADMET) = 541 ng ml-1 hr-1 PK study of the compound was carried to determine AUC (area under curve) value in rat ChEMBL. 12014955
Cp max (ADMET) = 221 ng ml-1 PK study of the compound was carried to determine the relative absorption ranking in rat. ChEMBL. 12014955
ED50 (functional) = 10 mg kg-1 Effective dose against LPS-stimulated Tumor necrosis factor, alpha release in mice dosed orally, 30 min prior to LPS challenge (0.1mg/kg,ip) ChEMBL. 12014955
ED50 (functional) = 10 mg kg-1 Effective dose against LPS-stimulated Tumor necrosis factor, alpha release in mice dosed orally, 30 min prior to LPS challenge (0.1mg/kg,ip) ChEMBL. 12014955
ED50 (functional) = 30 mg kg-1 Effective dose for suppressing paw swelling in an in vivo SCW (streptococcal cell wall) induced arthritis model in Lewis rat; value ranges from 10-30 ChEMBL. 12014955
IC50 (functional) = 2 nM Inhibition of p38-related TNF alpha release by human monocyte cell line (THP-1) ChEMBL. 12014955
IC50 (functional) = 2 nM Inhibition of p38-related TNF alpha release by human monocyte cell line (THP-1) ChEMBL. 12014955
IC50 (binding) = 4 nM Inhibition of murine Mitogen-activated protein kinase p38 ChEMBL. 12014955
IC50 (binding) = 4 nM Inhibition of murine Mitogen-activated protein kinase p38 ChEMBL. 12014955

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.